Physician profile
Richard J Brouillette
NPI 1063626836
$14,089.30
in general payments reported to CMS, 2019-2025
33 companies · $1,777 in 2025
The $1,777 reported for 2025 was more than what 75% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $778 · 2020: $356 · 2021: $702 · 2022: $6,194 · 2023: $2,170 · 2024: $2,112 · 2025: $1,777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,512 · Travel and Lodging: $1,547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,511.59 |
| Travel and Lodging | $1,547.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,239.44 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Ascenda |
| Boston Scientific Corporation | $2,409.74 | 2019-2025 | Infinion 16, Wavewriter Alpha Prime 16, General - Pain Management |
| Collegium Pharmaceutical, INC. | $1,000.58 | 2019-2025 | Xtampza, Belbuca |
| Spinefrontier, INC. | $622.78 | 2025 | Nanofuse, Facetfuse, Sijfuse |
| Vertos Medical, INC. | $502.62 | 2019-2024 | Mild Device Kit |
| Spinal Simplicity, LLC | $330.77 | 2022-2025 | Ha Minuteman G3-R |
| Mml US, INC. | $266.16 | 2024 | Reactiv8 |
| Abbott Laboratories | $204.25 | 2020-2025 | Proclaim |
| Medtronic USA, INC. | $200.27 | 2019-2020 | |
| Si-Bone, INC. | $181.68 | 2019 | |
| Globus Medical, INC. | $147.84 | 2025 | Senza |
| Nalu Medical, INC. | $131.18 | 2021-2025 | Nalu Neurostimulation System |
| Stimwave Technologies Incorporated | $121.65 | 2020-2021 | |
| Convatec INC. | $99.22 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $64.09 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $52.41 | 2019 | |
| Biotronik Nro, INC. | $48.63 | 2024 | Prospera |
| Allergan, INC. | $47.41 | 2019 | |
| Abbvie INC. | $44.41 | 2023 | Vraylar, Ubrelvy |
| Scilex Pharmaceuticals INC. | $44.23 | 2019-2022 | |
| Depuy Synthes Sales INC. | $41.32 | 2022 | |
| Almatica Pharma LLC | $37.66 | 2022-2023 | Gralise |
| Redhill Biopharma INC. | $35.87 | 2020 | |
| Flowonix Medical Incorporated | $32.95 | 2019 | |
| Stryker Corporation | $31.15 | 2025 | Mild Device Kit |
| Daiichi Sankyo INC. | $24.99 | 2019 | |
| Mdd US Operations, LLC | $22.66 | 2020 | |
| Averitas Pharma INC. | $21.51 | 2025 | Qutenza |
| Assertio Therapeutics, INC. | $21.43 | 2019 | |
| Kaleo, INC. | $20.37 | 2019 | |
| Pfizer INC. | $13.91 | 2019 | |
| Shionogi INC | $13.11 | 2019 | |
| Lilly USA, LLC | $13.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Brouillette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.